In children, hGH is officially authorized for therapy in the following indications: GHD Growth failure due to chronic renal insufficiency Noonan syndrome Prader-Willi syndrome Short bowel syndrome (SBS) Short stature homeobox (SHOX)-containing gene deficiency Small-for-gestational-age infants Turner syndrome In adults, hGH is also FDA-approved for therapy in: GHD SBS Muscle wasting due to AIDS Recombinant hGH therapy effectively increases serum growth hormone levels, addressing symptoms associated with GHD in both children and adults
doi:10.1007/s12664-017-0797-6
Peptides in Canada: Why Source Matters With the recent Canada Peptide shutdown , sourcing peptides safely has become even more critical
Brevetti, G., Attisano, T., Perna, S., Rossini, A., Policicchio, A., and Corsi, M
[DOI] [PubMed] [Google Scholar] 144.Berk M., Dean O.M., Cotton S.M., Jeavons S., Tanious M., Kohlmann K., Hewitt K., Moss K., Allwang C., Schapkaitz I., Robbins J., Cobb H., Ng F., Dodd S., Bush A.I., Malhi G.S